medical cannabis
medical cannabis · page 9
- Industry Trends
New Data Shows UK Medical Cannabis Industry Still Has a Gender Problem
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well behind its peers in one key area, data.
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- Prescribers & Clinics
High-THC Leads Growth as Australia Tightens TGA Prescribing Rules
The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of maturation, regulatory recalibration, and expanding export ambitions, according to new data.
- Clinical Research
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
- Clinical Research
How Cannabis Interacts with Pain, Sleep & Anxiety
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and a growing demand for alternatives to conventional pharmaceuticals.
- Clinical Research
Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our understanding of its use cases, and more importantly, fill the long-maligned gap in clinical evidence.
- Press releases
Why You Should Attend Business of Cannabis: New York
Industry leaders, regulators and investors meet at Business of Cannabis New York to discuss funding, regulation and sustainable market growth.
- UK & Europe
‘Significant Variation in Standards’ Found Across UK Medical Cannabis Pharmacies as ACMD Review Call Closes
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in 2018.
- UK & Europe
What Will ‘Czech Trump’ Mean for the Country’s Cannabis Industry?
The Czech Republic, long considered one of Europe’s most progressive countries on cannabis and wider drug reform, is entering a period of political transition following its parliamentary election earlier this month.
- Industry Trends
Speculation to Selectivity: Renewed Optimism Emerges Across Cannabis and Biotech Plays
Tilray Tilray has enjoyed a series of significant bumps in stock price over the last couple of weeks, driven largely by last week’s fervent speculation over the President’s social media posts.
- Press releases
Alternaleaf Launches UK’s First Women’s Health Cannabis Service
Alternaleaf, a UK-based medical cannabis clinic, has launched the country’s first women’s health service dedicated to cannabis-based treatments for gynaecological and hormonal conditions.
- UK & Europe
Legal Sources Now the First Choice for Cannabis Users in Germany
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the country’s most widely used illegal drug.
